Their results showed that nuclear HNF1B expression is limited in normal prostate (14%), PIN (0%) and CLC (23%), in comparison to the increased HNF1B expression in CRC (96%) and metastases (65%). The gene discussed is HNF1B; the disease is prostate intraepithelial neoplasia.